OnCusp Therapeutics Competitors and Similar CompaniesClear all
Seagen's competitors and similar companies include Mallinckrodt Pharmaceuticals.
 Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Mallinckrodt Pharmaceuticals Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. | |
Founding Date | Founding Date 1998 | Founding Date 1867 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Dublin 15, IE HQ Staines, GB Hazelwood, US Webster Groves, US |
Employees | Employees 3,25622% increase | Employees 3,373 |
Financial | ||
Revenue (est.) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $1b (FY, 2022) |
Cost of goods | Cost of goods $410.1m (FY, 2022) | Cost of goods $643.5m (FY, 2022) |
Gross profit | Gross profit $1.6b (FY, 2022) | Gross profit $396.2m (FY, 2022) |
Net income | Net income ($610.3m) (FY, 2022) | Net income ($598.3m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Mallinckrodt Pharmaceuticals
HQ
Dublin 15, IE
Employees
3,373
Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies.
View company